{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:03:52Z","timestamp":1789524232629,"version":"build-2803163510"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Bern"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Purpose of review<\/jats:title>\n                <jats:p>Critical illness myopathy (CIM) is a common neuro-muscular complication of intensive care treatment associated with increased morbidity and mortality. The current guidelines for diagnosis include clinical and electrophysiological criteria as well as a muscle biopsy, and allow diagnosis only at an advanced stage of the disease. To date, there is no treatment for CIM available, apart from symptomatic and rehabilitative interventions. In this review, we discuss different diagnostic approaches and describe new treatment possibilities for CIM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent findings<\/jats:title>\n                <jats:p>Of the diagnostic approaches evaluated, a new electrophysiological technique for measuring muscle excitability has the greatest potential to allow earlier diagnosis of CIM than the current guidelines do and thereby may facilitate the conduction of future pathophysiological and therapeutic studies. Although clinical trials are still lacking, in animal models, BGP-15, vamorolone, and ruxolitinib have been shown to have anti-inflammatory effects, to reduce muscle wasting and to improve muscle function and survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>In recent years, promising methods for early and confirmatory diagnosis of CIM have been developed, but still need validation. Experimental studies on novel pharmacological interventions show promising results in terms of preventive CIM treatments, but future clinical studies will be needed to study the effectiveness and safety of these drugs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11940-022-00714-7","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T14:03:42Z","timestamp":1648476222000},"page":"173-182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Critical Illness Myopathy: Diagnostic Approach and Resulting Therapeutic Implications"],"prefix":"10.1007","volume":"24","author":[{"given":"Bel\u00e9n","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner J.","family":"Z\u2019Graggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"issue":"10","key":"714_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S1474-4422(11)70178-8","volume":"10","author":"N Latronico","year":"2011","unstructured":"Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011;10(10):931\u201341.","journal-title":"Lancet Neurol"},{"issue":"9","key":"714_CR2","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00134-003-1894-9","volume":"29","author":"H Stibler","year":"2003","unstructured":"Stibler H, et al. Electrophoretic determination of the myosin\/actin ratio in the diagnosis of critical illness myopathy. Intensive Care Med. 2003;29(9):1515\u201327.","journal-title":"Intensive Care Med"},{"issue":"1\u20132","key":"714_CR3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0165-5728(99)00252-0","volume":"106","author":"MA De Letter","year":"2000","unstructured":"De Letter MA, et al. Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue. J Neuroimmunol. 2000;106(1\u20132):206\u201313.","journal-title":"J Neuroimmunol"},{"issue":"7","key":"714_CR4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1164\/rccm.201512-2344OC","volume":"194","author":"C Dos Santos","year":"2016","unstructured":"Dos Santos C, et al. Mechanisms of chronic muscle wasting and dysfunction after an intensive care unit stay. A pilot study. Am J Respir Crit Care Med. 2016;194(7):821\u201330.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"714_CR5","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s00134-014-3224-9","volume":"40","author":"T Wollersheim","year":"2014","unstructured":"Wollersheim T, et al. Dynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness. Intensive Care Med. 2014;40(4):528\u201338.","journal-title":"Intensive Care Med"},{"issue":"6","key":"714_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1046\/j.1365-2990.1998.00144.x","volume":"24","author":"TR Helliwell","year":"1998","unstructured":"Helliwell TR, et al. Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin. Neuropathol Appl Neurobiol. 1998;24(6):507\u201317.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"15","key":"714_CR7","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1001\/jama.2013.278481","volume":"310","author":"ZA Puthucheary","year":"2013","unstructured":"Puthucheary ZA, et al. Acute skeletal muscle wasting in critical illness. JAMA. 2013;310(15):1591\u2013600.","journal-title":"JAMA"},{"issue":"2","key":"714_CR8","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/CCM.0b013e31823295e6","volume":"40","author":"J Bierbrauer","year":"2012","unstructured":"Bierbrauer J, et al. Early type II fiber atrophy in intensive care unit patients with nonexcitable muscle membrane. Crit Care Med. 2012;40(2):647\u201350.","journal-title":"Crit Care Med"},{"issue":"11","key":"714_CR9","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1007\/s00134-007-0772-2","volume":"33","author":"RD Stevens","year":"2007","unstructured":"Stevens RD, et al. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med. 2007;33(11):1876\u201391.","journal-title":"Intensive Care Med"},{"issue":"4","key":"714_CR10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/01.CCM.0000157969.46388.A2","volume":"33","author":"S Bercker","year":"2005","unstructured":"Bercker S, et al. Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med. 2005;33(4):711\u20135.","journal-title":"Crit Care Med"},{"issue":"5","key":"714_CR11","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1164\/rccm.200605-665OC","volume":"175","author":"G Hermans","year":"2007","unstructured":"Hermans G, et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med. 2007;175(5):480\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"714_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s001340050669","volume":"24","author":"JH Coakley","year":"1998","unstructured":"Coakley JH, et al. Patterns of neurophysiological abnormality in prolonged critical illness. Intensive Care Med. 1998;24(8):801\u20137.","journal-title":"Intensive Care Med"},{"issue":"2","key":"714_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1164\/ajrccm\/146.2.517","volume":"146","author":"JA Douglass","year":"1992","unstructured":"Douglass JA, et al. Myopathy in severe asthma. Am Rev Respir Dis. 1992;146(2):517\u20139.","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"714_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/1751143714563016","volume":"16","author":"RT Appleton","year":"2015","unstructured":"Appleton RT, Kinsella J, Quasim T. The incidence of intensive care unit-acquired weakness syndromes: a systematic review. J Intensive Care Soc. 2015;16(2):126\u201336.","journal-title":"J Intensive Care Soc"},{"key":"714_CR15","doi-asserted-by":"crossref","unstructured":"Frithiof R, et al, Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: a prospective study. Clin Neurophysiol. 2021.","DOI":"10.1016\/j.clinph.2021.03.016"},{"issue":"12","key":"714_CR16","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1016\/j.clinph.2020.09.017","volume":"131","author":"L Cabanes-Martinez","year":"2020","unstructured":"Cabanes-Martinez L, et al. Neuromuscular involvement in COVID-19 critically ill patients. Clin Neurophysiol. 2020;131(12):2809\u201316.","journal-title":"Clin Neurophysiol"},{"key":"714_CR17","doi-asserted-by":"publisher","unstructured":"Rodriguez B, Branca M, Gutt-Will M, Roth M, S\u00f6ll N, Cameron DR, Tankisi H, Tan SV, Bostock H, Raabe A, Schefold JC, Jakob SM, Z\u2019Graggen WJ.\u00a0Development and early diagnosis of critical illness myopathy in COVID-19 associated acute respiratory distress syndrome. J Cachexia Sarcopenia Muscle. under review. https:\/\/doi.org\/10.1002\/jcsm.12989","DOI":"10.1002\/jcsm.12989"},{"issue":"3","key":"714_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/mus.24175","volume":"50","author":"S Koch","year":"2014","unstructured":"Koch S, et al. Long-term recovery In critical illness myopathy is complete, contrary to polyneuropathy. Muscle Nerve. 2014;50(3):431\u20136.","journal-title":"Muscle Nerve"},{"issue":"6","key":"714_CR19","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.clinph.2021.03.010","volume":"132","author":"K Ng","year":"2021","unstructured":"Ng K. A new examination of critical illness myopathy. Clin Neurophysiol. 2021;132(6):1332\u20133.","journal-title":"Clin Neurophysiol"},{"issue":"Pt 9","key":"714_CR20","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1093\/brain\/awl191","volume":"129","author":"WJ Z'Graggen","year":"2006","unstructured":"Z\u2019Graggen WJ, et al. Nerve excitability changes in critical illness polyneuropathy. Brain. 2006;129(Pt 9):2461\u201370.","journal-title":"Brain"},{"issue":"3","key":"714_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1136\/jnnp.2009.192997","volume":"82","author":"S Koch","year":"2011","unstructured":"Koch S, et al. Critical illness myopathy is frequent: accompanying neuropathy protracts ICU discharge. J Neurol Neurosurg Psychiatry. 2011;82(3):287\u201393.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"714_CR22","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJMoa1011802","volume":"364","author":"MS Herridge","year":"2011","unstructured":"Herridge MS, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364(14):1293\u2013304.","journal-title":"N Engl J Med"},{"issue":"4","key":"714_CR23","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1164\/rccm.201312-2257OC","volume":"190","author":"G Hermans","year":"2014","unstructured":"Hermans G, et al. Acute outcomes and 1-year mortality of intensive care unit-acquired weakness a cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2014;190(4):410\u201320.","journal-title":"Am J Respir Crit Care Med"},{"key":"714_CR24","unstructured":"Kamdar BB, et al.\u00a0Joblessness and lost earnings after ARDS in a 1-year national multicenter study abstracts. Am J Respir Crit Care Med.\u00a02017;196(8)."},{"issue":"3","key":"714_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1164\/rccm.200712-1829OC","volume":"178","author":"NA Ali","year":"2008","unstructured":"Ali NA, et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med. 2008;178(3):261\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"714_CR26","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1136\/thoraxjnl-2018-213020","volume":"74","author":"G Hermans","year":"2019","unstructured":"Hermans G, et al. Five-year mortality and morbidity impact of prolonged versus brief ICU stay: a propensity score matched cohort study. Thorax. 2019;74(11):1037\u201345.","journal-title":"Thorax"},{"issue":"3","key":"714_CR27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/CCM.0000000000002208","volume":"45","author":"VD Dinglas","year":"2017","unstructured":"Dinglas VD, et al. Muscle weakness and 5-year survival in acute respiratory distress syndrome survivors. Crit Care Med. 2017;45(3):446\u201353.","journal-title":"Crit Care Med"},{"issue":"12","key":"714_CR28","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1097\/CCM.0b013e3181b027e9","volume":"37","author":"T Sharshar","year":"2009","unstructured":"Sharshar T, et al. Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality. Crit Care Med. 2009;37(12):3047\u201353.","journal-title":"Crit Care Med"},{"issue":"6","key":"714_CR29","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1007\/s00134-020-05927-5","volume":"46","author":"N Van Aerde","year":"2020","unstructured":"\u2022 Van Aerde N, et al. Five-year impact of ICU-acquired neuromuscular complications: a prospective, observational study. Intensive Care Med. 2020;46(6):1184\u201393. This study prospectively investigated the association between intensive care\u2013aquired neuromuscular complications and 5-year mortality and morbidity in a large sample size of critically ill patients. They concluded that the impact of neuromuscular complications goes beyond the acute phase of critical illness and does correlate with 5-year outcomes, and found that even mildly reduced strength at discharge of the intensive care unit was related to worse 5-year outcomes.","journal-title":"Intensive Care Med"},{"issue":"4","key":"714_CR30","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/CCM.0000000000000040","volume":"42","author":"E Fan","year":"2014","unstructured":"Fan E, et al. Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit Care Med. 2014;42(4):849\u201359.","journal-title":"Crit Care Med"},{"key":"714_CR31","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13054-015-0937-2","volume":"19","author":"L Wieske","year":"2015","unstructured":"Wieske L, et al. Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up study. Crit Care. 2015;19:196.","journal-title":"Crit Care"},{"key":"714_CR32","doi-asserted-by":"crossref","unstructured":"Weber-Carstens S, et al.\u00a0Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study. Crit Care. 2010;14(3).","DOI":"10.1186\/cc9074"},{"issue":"12","key":"714_CR33","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1097\/00003246-200112000-00008","volume":"29","author":"M de Letter","year":"2001","unstructured":"de Letter M, et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med. 2001;29(12):2281\u20136.","journal-title":"Crit Care Med"},{"issue":"3","key":"714_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1600-0404.2008.00996.x","volume":"118","author":"S Nanas","year":"2008","unstructured":"Nanas S, et al. Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit. Acta Neurol Scand. 2008;118(3):175\u201381.","journal-title":"Acta Neurol Scand"},{"issue":"15","key":"714_CR35","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jama.1995.03530150045032","volume":"274","author":"FS Leijten","year":"1995","unstructured":"Leijten FS, et al. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA. 1995;274(15):1221\u20135.","journal-title":"JAMA"},{"key":"714_CR36","doi-asserted-by":"crossref","unstructured":"Latronico N, et al.\u00a0Validation of the peroneal nerve test to diagnose critical illness polyneuropathy and myopathy in the intensive care unit: the multicentre Italian CRIMYNE-2 diagnostic accuracy study. F1000Res. 2014;3:127.","DOI":"10.12688\/f1000research.3933.1"},{"issue":"22","key":"714_CR37","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1001\/jama.288.22.2859","volume":"288","author":"B De Jonghe","year":"2002","unstructured":"De Jonghe B, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288(22):2859\u201367.","journal-title":"JAMA"},{"issue":"3","key":"714_CR38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00415-005-0654-x","volume":"252","author":"J Bednarik","year":"2005","unstructured":"Bednarik J, et al. Risk factors for critical illness polyneuromyopathy. J Neurol. 2005;252(3):343\u201351.","journal-title":"J Neurol"},{"issue":"1","key":"714_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00134-004-2509-9","volume":"31","author":"R Amaya-Villar","year":"2005","unstructured":"Amaya-Villar R, et al. Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease. Intensive Care Med. 2005;31(1):157\u201361.","journal-title":"Intensive Care Med"},{"issue":"8","key":"714_CR40","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1007\/s001340101009","volume":"27","author":"J Garnacho-Montero","year":"2001","unstructured":"Garnacho-Montero J, et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med. 2001;27(8):1288\u201396.","journal-title":"Intensive Care Med"},{"issue":"6","key":"714_CR41","doi-asserted-by":"publisher","first-page":"484","DOI":"10.7326\/0003-4819-117-6-484","volume":"117","author":"Y Kupfer","year":"1992","unstructured":"Kupfer Y, et al. Prolonged weakness after long-term infusion of vecuronium bromide. Ann Intern Med. 1992;117(6):484\u20136.","journal-title":"Ann Intern Med"},{"issue":"4","key":"714_CR42","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/jnnp.2005.070813","volume":"77","author":"JP Lefaucheur","year":"2006","unstructured":"Lefaucheur JP, et al. Origin of ICU acquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatry. 2006;77(4):500\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"714_CR43","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/00003246-199610000-00024","volume":"24","author":"MI Rudis","year":"1996","unstructured":"Rudis MI, et al. Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unit. Crit Care Med. 1996;24(10):1749\u201356.","journal-title":"Crit Care Med"},{"issue":"6","key":"714_CR44","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S1010-7940(97)00273-X","volume":"12","author":"RI Thiele","year":"1997","unstructured":"Thiele RI, et al. Critical illness polyneuropathy: a new iatrogenically induced syndrome after cardiac surgery? Eur J Cardiothorac Surg. 1997;12(6):826\u201335.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"8","key":"714_CR45","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1212\/01.WNL.0000158442.08857.FC","volume":"64","author":"G Van den Berghe","year":"2005","unstructured":"Van den Berghe G, et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005;64(8):1348\u201353.","journal-title":"Neurology"},{"issue":"1","key":"714_CR46","first-page":"46","volume":"11","author":"S Finfer","year":"2009","unstructured":"Finfer S, et al. The NICE-SUGAR (normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation) study: statistical analysis plan. Crit Care Resusc. 2009;11(1):46\u201357.","journal-title":"Crit Care Resusc"},{"issue":"13","key":"714_CR47","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","volume":"360","author":"N-SS Investigators","year":"2009","unstructured":"Investigators N-SS, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283\u201397.","journal-title":"N Engl J Med"},{"issue":"2","key":"714_CR48","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.mehy.2008.03.022","volume":"71","author":"JC Schefold","year":"2008","unstructured":"Schefold JC, et al. Sepsis: time has come to focus on the later stages. Med Hypotheses. 2008;71(2):203\u20138.","journal-title":"Med Hypotheses"},{"issue":"6","key":"714_CR49","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00134-004-2174-z","volume":"30","author":"B De Jonghe","year":"2004","unstructured":"De Jonghe B, et al. Does ICU-acquired paresis lengthen weaning from mechanical ventilation?. Intensive Care Med. 2004;30(6):1117\u201321.","journal-title":"Intensive Care Med"},{"issue":"9","key":"714_CR50","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1097\/01.ccm.0000281450.01881.d8","volume":"35","author":"B De Jonghe","year":"2007","unstructured":"De Jonghe B, et al. Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med. 2007;35(9):2007\u201315.","journal-title":"Crit Care Med"},{"key":"714_CR51","doi-asserted-by":"crossref","unstructured":"Cheung K, et al. Pathophysiology and management of critical illness polyneuropathy and myopathy. J Appl Physiol (1985). 2021;130(5):1479\u20131489.","DOI":"10.1152\/japplphysiol.00019.2021"},{"key":"714_CR52","doi-asserted-by":"crossref","unstructured":"Schefold JC, et al.\u00a0Muscular weakness and muscle wasting in the critically ill. J Cachexia Sarcopenia Muscle.\u00a02020.","DOI":"10.1002\/jcsm.12620"},{"issue":"1","key":"714_CR53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mus.20884","volume":"37","author":"DC Allen","year":"2008","unstructured":"Allen DC, Arunachalam R, Mills KR. Critical illness myopathy: further evidence from muscle-fiber excitability studies of an acquired channelopathy. Muscle Nerve. 2008;37(1):14\u201322.","journal-title":"Muscle Nerve"},{"key":"714_CR54","doi-asserted-by":"crossref","unstructured":"\u2022 Tankisi A, et al.\u00a0Early detection of evolving critical illness myopathy with muscle velocity recovery cycles. Clin Neurophysiol.\u00a02021.\u00a0This study prospectively investigated the sensitivity of measuring muscle velocity recovery cycles, an electrophysiological technique to measure muscle excitability, for detection of altered membrane properties in critically ill patients. They report that muscle velocity recovery cycles showed 100% sensitivity and specificity in distinguishing patients from controls, and can detect changes in patients with intensive care unit\u2013acquired weakness not yet fulfilling diagnostic criteria for critical illness myopathy. They conclude that this electrophysiological technique of measuring muscle excitability may serve as a tool for early detection of evolving critical illness myopathy.","DOI":"10.1016\/j.clinph.2021.01.017"},{"issue":"6","key":"714_CR55","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/(SICI)1097-4598(199706)20:6<665::AID-MUS2>3.0.CO;2-6","volume":"20","author":"MM Rich","year":"1997","unstructured":"Rich MM, et al. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve. 1997;20(6):665\u201373.","journal-title":"Muscle Nerve"},{"issue":"3","key":"714_CR56","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/WNP.0000000000000652","volume":"37","author":"WJ Z'Graggen","year":"2020","unstructured":"Z\u2019Graggen WJ, Tankisi H. Critical illness myopathy. J Clin Neurophysiol. 2020;37(3):200\u20134.","journal-title":"J Clin Neurophysiol"},{"key":"714_CR57","doi-asserted-by":"crossref","unstructured":"\u2022 Marrero H, et al.\u00a0Neurogenic vs. myogenic origin of acquired muscle paralysis in intensive care unit (ICU) patients: evaluation of different diagnostic methods. Diagnostics (Basel). 2020;10(11). This study highlights the importance of differentiation between acquired muscle paralysis of neurogenic vs. myogenic origin and explores different diagnostic techniques for this purpose. They conclude that while conventional electrophysiological methods may be able to identify muscle paralysis, they do not reliably differentiate between neurogenic and myogenic origins, and propose repeated microbiopsy of the muscle as a diagnostic method.","DOI":"10.3390\/diagnostics10110966"},{"issue":"22","key":"714_CR58","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1001\/jama.288.22.2859","volume":"288","author":"B De Jonghe","year":"2002","unstructured":"De Jonghe B, et al. Paresis acquired in the intensive care unit - a prospective multicenter study. Jama-J Am Med Assoc. 2002;288(22):2859\u201367.","journal-title":"Jama-J Am Med Assoc"},{"issue":"3","key":"714_CR59","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1056\/NEJMc1406274","volume":"371","author":"JP Kress","year":"2014","unstructured":"Kress JP, Hall JB. ICU-acquired weakness and recovery from critical illness. N Engl J Med. 2014;371(3):287\u20138.","journal-title":"N Engl J Med"},{"issue":"5","key":"714_CR60","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/jnnp.2008.157263","volume":"8","author":"RS Howard","year":"2008","unstructured":"Howard RS, Tan SV, Z\u2019Graggen WJ. Weakness on the intensive care unit. Pract Neurol. 2008;8(5):280\u201395.","journal-title":"Pract Neurol"},{"issue":"1","key":"714_CR61","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1172\/JCI106483","volume":"50","author":"JN Cunningham Jr","year":"1971","unstructured":"Cunningham JN Jr, et al. Resting transmembrane potential difference of skeletal muscle in normal subjects and severely ill patients. J Clin Invest. 1971;50(1):49\u201359.","journal-title":"J Clin Invest"},{"issue":"3","key":"714_CR62","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1212\/WNL.46.3.731","volume":"46","author":"MM Rich","year":"1996","unstructured":"Rich MM, et al. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology. 1996;46(3):731\u20136.","journal-title":"Neurology"},{"issue":"9","key":"714_CR63","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1097\/CCM.0b013e3181a92f28","volume":"37","author":"S Weber-Carstens","year":"2009","unstructured":"Weber-Carstens S, et al. Nonexcitable muscle membrane predicts intensive care unit-acquired paresis in mechanically ventilated, sedated patients. Crit Care Med. 2009;37(9):2632\u20137.","journal-title":"Crit Care Med"},{"issue":"1","key":"714_CR64","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/ana.1016","volume":"50","author":"MM Rich","year":"2001","unstructured":"Rich MM, Pinter MJ. Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann Neurol. 2001;50(1):26\u201333.","journal-title":"Ann Neurol"},{"issue":"Pt 2","key":"714_CR65","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1113\/jphysiol.2002.035188","volume":"547","author":"MM Rich","year":"2003","unstructured":"Rich MM, Pinter MJ. Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol. 2003;547(Pt 2):555\u201366.","journal-title":"J Physiol"},{"issue":"5\u20137","key":"714_CR66","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10974-006-9074-5","volume":"27","author":"JW Teener","year":"2006","unstructured":"Teener JW, Rich MM. Dysregulation of sodium channel gating in critical illness myopathy. J Muscle Res Cell Motil. 2006;27(5\u20137):291\u20136.","journal-title":"J Muscle Res Cell Motil"},{"issue":"4","key":"714_CR67","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1097\/CCM.0b013e31816a02cf","volume":"36","author":"G Haeseler","year":"2008","unstructured":"Haeseler G, et al. Endotoxin reduces availability of voltage-gated human skeletal muscle sodium channels at depolarized membrane potentials. Crit Care Med. 2008;36(4):1239\u201347.","journal-title":"Crit Care Med"},{"issue":"5","key":"714_CR68","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/mus.21192","volume":"39","author":"WJ Z'Graggen","year":"2009","unstructured":"Z\u2019Graggen WJ, Bostock H. Velocity recovery cycles of human muscle action potentials and their sensitivity to ischemia. Muscle Nerve. 2009;39(5):616\u201326.","journal-title":"Muscle Nerve"},{"issue":"1","key":"714_CR69","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/mus.23267","volume":"46","author":"D Boerio","year":"2012","unstructured":"Boerio D, et al. Muscle velocity recovery cycles: effects of repetitive stimulation on two muscles. Muscle Nerve. 2012;46(1):102\u201311.","journal-title":"Muscle Nerve"},{"key":"714_CR70","doi-asserted-by":"publisher","unstructured":"Witt A, Bostock H, Z'Graggen WJ, Tan SV, Kristensen AG, Kristensen RS, Larsen LH, Zeppelin Z, Tankisi H.\u00a0 Muscle velocity recovery cycles to examine muscle membrane properties. JoVE (Journal of Visualized Experiments) 2020;(156):10.3791\/60788. https:\/\/doi.org\/10.3791\/60788. (PMID: 32150167).","DOI":"10.3791\/60788"},{"issue":"1","key":"714_CR71","first-page":"187","volume":"79","author":"J Bergmans","year":"1971","unstructured":"Bergmans J. The negative after potential of human muscle fibres. Arch Int Physiol Biochim. 1971;79(1):187\u20138.","journal-title":"Arch Int Physiol Biochim"},{"issue":"4","key":"714_CR72","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.clinph.2010.09.024","volume":"122","author":"WJ Z'Graggen","year":"2011","unstructured":"Z\u2019Graggen WJ, et al. Muscle membrane dysfunction in critical illness myopathy assessed by velocity recovery cycles. Clin Neurophysiol. 2011;122(4):834\u201341.","journal-title":"Clin Neurophysiol"},{"key":"714_CR73","doi-asserted-by":"crossref","unstructured":"Ackermann KA et al.\u00a0Early changes of muscle membrane properties in porcine faecal peritonitis. Crit Care. 2014;18(4).","DOI":"10.1186\/s13054-014-0484-2"},{"issue":"5","key":"714_CR74","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/mus.26013","volume":"57","author":"D Boerio","year":"2018","unstructured":"Boerio D, et al. Muscle membrane properties in A pig sepsis model: effect of norepinephrine. Muscle Nerve. 2018;57(5):808\u201313.","journal-title":"Muscle Nerve"},{"key":"714_CR75","doi-asserted-by":"crossref","unstructured":"Hermans G, et al. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev.\u00a02014;(1):CD006832.","DOI":"10.1002\/14651858.CD006832.pub3"},{"issue":"1","key":"714_CR76","doi-asserted-by":"publisher","first-page":"e13425","DOI":"10.1111\/apha.13425","volume":"229","author":"N Cacciani","year":"2020","unstructured":"\u2022 Cacciani N, et al. Chaperone co-inducer BGP-15 mitigates early contractile dysfunction of the soleus muscle in a rat ICU model. Acta Physiol (Oxf). 2020;229(1):e13425 This experimental animal study describes and investigates a new therapeutic approach for critical illness myopathy. BGP-15 treatment improved muscle fiber and motor protein function.","journal-title":"Acta Physiol (Oxf)"},{"key":"714_CR77","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.steroids.2018.02.010","volume":"134","author":"EP Hoffman","year":"2018","unstructured":"Hoffman EP, et al. Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes. Steroids. 2018;134:43\u201352.","journal-title":"Steroids"},{"issue":"2","key":"714_CR78","doi-asserted-by":"publisher","first-page":"e13172","DOI":"10.1111\/apha.13172","volume":"225","author":"H Akkad","year":"2019","unstructured":"\u2022 Akkad H, et al. Vamorolone treatment improves skeletal muscle outcome in a critical illness myopathy rat model. Acta Physiol (Oxf). 2019;225(2):e13172. This experimental animal study describes and investigates a new therapeutic approach for critical illness myopathy. The results of this study indicate that vamorolone provides a glucocorticoid intervention superior to typical glucocorticoids in improving outcome in critical illness myopathy.","journal-title":"Acta Physiol (Oxf)"},{"issue":"11","key":"714_CR79","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1113\/JP281220","volume":"599","author":"AB Addinsall","year":"2021","unstructured":"\u2022 Addinsall AB, et al. JAK\/STAT inhibition augments soleus muscle function in a rat model of critical illness myopathy via regulation of complement C3\/3R. J Physiol. 2021;599(11):2869\u201386. This experimental animal study describes and investigates a new therapeutic approach for critical illness myopathy. The results show that JAK\/STAT inhibition improves muscle function and augments muscle function in critical illness myopathy.","journal-title":"J Physiol"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-022-00714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11940-022-00714-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-022-00714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T06:19:03Z","timestamp":1652422743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11940-022-00714-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["714"],"URL":"https:\/\/doi.org\/10.1007\/s11940-022-00714-7","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"assertion":[{"value":"8 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Bel\u00e9n Rodriguez declares that she has no conflict of interest. Lars Larsson declares that he has no conflict of interest. Werner J. Z\u2019Graggen declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}